A cost-effectiveness analysis of three approaches for lymph node assessment in patients with low- and intermediate-risk endometrial cancer

•Sentinel lymph node mapping is the most cost-effective strategy for patients with low- and intermediate-risk endometrial cancer•Sentinel lymph node mapping is more costly than risk factor assessment, but the costs stay below the willingness-to-pay threshold.•Sentinel lymph node mapping is dominant compared to lymph node dissection.